Georgia Center for Diabetes Translation Research

佐治亚州糖尿病翻译研究中心

• 批准号: 10290780
• 负责人: Kabayam M Venkat Narayan
• 金额: $ 75万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-16 至 2026-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10290780
• 关键词: Acquired Immunodeficiency Syndrome; Address; Adoption; Affect; Award; Behavior; Behavioral Sciences; Businesses; COVID-19; Cardiovascular Diseases; Caring; Centers for Disease Control and Prevention (U.S.); Clinical; Clinical Sciences; Collaborations; Communities; Community Health Systems; Country; Data; Decision Making; Diabetes Mellitus; Diabetes prevention; Discipline of Nursing; Economically Deprived Population; Effectiveness; Elderly; Emerging Technologies; Engineering; Ethnic group; Evaluation; Faculty; Failure; Florida; Funding; Future; Geography; Government; Grant; HIV; Health; Health Promotion; Health Sciences; Health system; Home; Institutes; Institution; Intervention; K-Series Research Career Programs; Knowledge; Leadership; Learning; Life; Local Government; Maintenance; Measurement; Medicine; Mental Depression; Metabolic; Methodology; Minority; Modeling; Morehouse School of Medicine; Outcome; Policies; Population Heterogeneity; Postdoctoral Fellow; Prevention; Public Health Schools; Race; Research; Research Infrastructure; Research Personnel; Resource Sharing; Resources; Rural; School Nursing; Schools; Science; Scientist; Seeds; Services; Subgroup; Talents; Technology; Tennessee; Translating; Translational Research; Translations; Underserved Population; United States National Institutes of Health; Universities; Vision; Vulnerable Populations; Work; base; behavioral economics; behavioral pharmacology; career; cohesion; community setting; comorbidity; cost; design; diabetes management; diabetes risk; disadvantaged population; economic cost; ethnic disadvantage; evidence base; experience; health disparity; health disparity populations; health equity; health equity promotion; high risk; improved; innovation; innovative technologies; knowledge translation; medical schools; member; multidisciplinary; next generation; prevent; programs; racial minority; recruit; social; social disadvantage; socioeconomic disadvantage; socioeconomics; success; underserved area

OVERVIEW: PROJECT SUMMARY / ABSTRACT While considerable evidence is available for prevention and care of diabetes, huge gaps remain in equitable and sustainable translation of this knowledge into practice and policy in clinical and community settings. To close these gaps, the Georgia Center for Diabetes Translation Research (GCDTR), has leveraged the multidisciplinary expertise and experience in Atlanta, by bringing together collaborations among researchers from several leading institutions, namely, Emory's Rollins School of Public Health, School of Medicine, School of Nursing, and Goizueta Business School; Georgia Institute of Technology; and Morehouse School of Medicine. Having successfully expanded the translation research (from $15 to $33 million annually), and investigators (from 38 to 102 members, including 26 newly recruited diabetes faculty) bases, GCDTR will embrace the vision of equity and strive to close the gaps in diabetes prevention and care across demographic and comorbid groups, especially in socially, economically, and ethnically disadvantaged populations. GCDTR will include an Administrative Core A, seamlessly coordinating three interconnected translation research cores: (1) Core B, Design and Evaluation for Equity, emphasizing measurement and learning from previous experiences—both successes and failures—through appropriate metrics and evaluation and innovating for the future (design) to help stimulate progress; (2) Core C, Socio-ecological and Behavioral Sciences for Equity, bringing a wealth of interdisciplinary experiences in developing theoretically-based interventions and innovative, technology-driven engagement methodologies promoting the adoption and maintenance of health- promoting behaviors among vulnerable populations; and (3) a Regional Core, Technologies Advancing Translation and Equity, and expanding partnerships to include institution in neighboring Florida and Tennessee – southeastern states that have historically had large underserved areas and populations at high risk for diabetes. Enrichment and Pilot and Feasibility Programs will continue to enhance young and transitioning investigators' capacity to be competitive for NIH funds in translation research and have impact on diabetes prevention and care. This multi-institutional, multidisciplinary center, involving over 120 members, brings considerable breadth and depth of research expertise, a substantial research base, and leverages several NIH-funded Centers, namely, the Georgia Clinical and Translational Science Alliance (GaCTSA), Center for AIDS Research (CFAR), and the AHA-funded Morehouse/Emory Center for Health Equity. Proximity to and relationships with the Division of Diabetes Translation at the US Centers for Disease Control and Prevention (CDC) also offers GCDTR many unique assets. Furthermore, we have instituted several innovations, and obtained strong institutional support and commitments (totaling $857,500 over 5 years), and leveraged a variety of doctoral and post-doctoral programs to develop an efficient, effective, and integrated center.

概述：项目总结/摘要 虽然有相当多的证据可用于糖尿病的预防和护理，但在公平方面仍存在巨大差距。 并将这些知识可持续地转化为临床和社区环境中的实践和政策。到 为了缩小这些差距，格鲁吉亚糖尿病翻译研究中心（GCDTR）利用了 多学科的专业知识和经验，在亚特兰大，通过汇集研究人员之间的合作， 来自几个领先的机构，即埃默里大学罗林斯公共卫生学院，医学院，学校 护理学院、戈伊苏埃塔商学院、格鲁吉亚理工学院和莫尔豪斯商学院 药成功地扩大了翻译研究（从每年1500万美元增加到3300万美元）， 研究人员（从38到102名成员，包括26名新招募的糖尿病教师）基地，GCDTR将 接受公平的愿景，努力缩小各人口群体在糖尿病预防和护理方面的差距， 和共病群体，特别是在社会，经济和种族弱势群体。GCDTR 将包括一个行政核心A，无缝协调三个相互关联的翻译研究核心： (1)核心B，公平的设计和评价，强调衡量和从以前的经验中学习 通过适当的衡量标准和评估， 未来（设计），以帮助刺激进步;（2）核心C，社会生态和行为科学的公平， 在制定基于理论的干预措施方面带来丰富的跨学科经验， 创新的，技术驱动的参与方法，促进采用和维护健康- 促进弱势群体的行为;（3）区域核心，技术进步 翻译和公平，并扩大伙伴关系，包括在邻近的佛罗里达和田纳西州的机构 - 东南部各州历史上有大量服务不足的地区和人口， 糖尿病丰富和试点和可行性计划将继续加强年轻和过渡 研究人员在翻译研究中对NIH基金具有竞争力并对糖尿病产生影响的能力 预防和护理。这个多机构，多学科中心，涉及120多名成员，带来了 相当的广度和深度的研究专业知识，一个坚实的研究基础，并利用几个 NIH资助的中心，即格鲁吉亚临床和转化科学联盟（GaCTSA）， 艾滋病研究（CFAR）和AHA资助的莫尔豪斯/埃默里健康公平中心。接近和 与美国疾病控制和预防中心糖尿病翻译部的关系 (CDC)还为GCDTR提供了许多独特的资产。此外，我们还进行了一些创新， 获得了强有力的机构支持和承诺（5年总计857，500美元），并利用了 各种博士和博士后项目，以发展一个高效，有效和综合的中心。